Strong Industry Position Viatris operates within the highly competitive pharmaceutical manufacturing sector with a substantial workforce of over 10,000 employees and revenue ranging between 1 to 10 billion dollars, indicating significant market presence and growth potential.

Innovative R&D Collaborations Recent partnerships with biotech firms like Locus Biosciences and Theravance highlight Viatris's focus on developing cutting-edge treatments such as precision antibacterials and therapies for COPD, presenting opportunities for supply chain and technology solutions in biotech collaborations.

Sustainability & Recognition Viatris has been recognized as a Fortune World's Best Workplace, demonstrating a strong employer brand and stable organizational culture that can attract top talent and foster innovation in pharmaceutical solutions.

Digital & Data-Driven Approach Utilizing advanced tech stacks including Medallia, Snowflake, Oracle, and Kronos signals a focus on digital transformation and optimized operations, offering potential sales avenues in enterprise software or analytics solutions.

Expanding Global Footprint The acquisition of Aculys Pharma and rights in the Asia-Pacific markets show Viatris's strategic global expansion, creating sales opportunities in regional markets, supply chain management, and localized healthcare solutions.